Cargando…

Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition

Detalles Bibliográficos
Autores principales:	Terzo, Esteban A., Lim, Aaron R., Chytil, Anna, Chiang, Yun Chen, Farmer, Leah, Gessner, Kathryn H., Walker, Cheryl Lyn, Jansen, Valerie M., Rathmell, W. Kimryn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824879/ https://www.ncbi.nlm.nih.gov/pubmed/31695846 http://dx.doi.org/10.18632/oncotarget.27288

Ejemplares similares

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

Molecular determinants for α-tubulin methylation by SETD2
por: Kearns, Sarah, et al.
Publicado: (2021)

The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase
por: Seervai, Riyad N. H., et al.
Publicado: (2020)

Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy
por: Rojas, Juan D., et al.
Publicado: (2018)

SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
por: Huang, Jianyi, et al.
Publicado: (2022)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020)

VHL Type 2B Mutations Retain VBC Complex Form and Function
por: Hacker, Kathryn E., et al.
Publicado: (2008)

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

Renal cell carcinoma
por: Jonasch, Eric, et al.
Publicado: (2014)

The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021)

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
por: Sendor, Adam B, et al.
Publicado: (2015)

Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies
por: Rathmell, Kimryn W., et al.
Publicado: (2015)

Epigenotype–genotype–phenotype correlations in SETD1A and SETD2 chromatin disorders
por: Lee, Sunwoo, et al.
Publicado: (2023)

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2
por: Moffitt, Andrea B., et al.
Publicado: (2017)

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
por: Javaid, Hira, et al.
Publicado: (2023)

HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells
por: Arreola, Alexandra, et al.
Publicado: (2014)

The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
por: Chiang, Chengyao, et al.
Publicado: (2022)

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response
por: DeSimone, Michelle C., et al.
Publicado: (2013)

Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate
por: Schuhmacher, Maren Kirstin, et al.
Publicado: (2020)

SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling
por: Li, Xiaoxue, et al.
Publicado: (2021)

Integrative computational immunogenomic profiling of cortisol‐secreting adrenocortical carcinoma
por: Baechle, Jordan J., et al.
Publicado: (2021)

Developmental disruption to the cortical transcriptome and synaptosome in a model of SETD1A loss-of-function
por: Clifton, Nicholas E, et al.
Publicado: (2022)

Loss of H3K36 Methyltransferase SETD2 Impairs V(D)J Recombination during Lymphoid Development
por: Chu, S. Haihua, et al.
Publicado: (2020)

Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
por: Simon, Jeremy M., et al.
Publicado: (2014)

Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
por: Shi, Jing, et al.
Publicado: (2023)

Proteomic analysis of SETD6 interacting proteins
por: Cohn, Ofir, et al.
Publicado: (2016)

Phenotypic characterization of SETD3 knockout Drosophila
por: Tiebe, Marcel, et al.
Publicado: (2018)

Insights into the stereoselectivity of human SETD7 methyltransferase
por: Tang, Bowen, et al.
Publicado: (2019)

Author Correction: Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate
por: Schuhmacher, Maren Kirstin, et al.
Publicado: (2020)

Metabolic regulation of Akt: roles reversed
por: Coloff, Jonathan L., et al.
Publicado: (2006)

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
por: Samartzis, Eleftherios P, et al.
Publicado: (2014)

Eldecalcitol prevents muscle loss by suppressing PI3K/AKT/FOXOs pathway in orchiectomized mice
por: Zhang, Haichao, et al.
Publicado: (2022)

setd2 knockout zebrafish is viable and fertile: differential and developmental stress-related requirements for Setd2 and histone H3K36 trimethylation in different vertebrate animals
por: Liu, Dian-Jia, et al.
Publicado: (2020)

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
por: Beckermann, Kathryn E., et al.
Publicado: (2017)

Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
por: Pecce, Valeria, et al.
Publicado: (2020)

Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
por: Ma, Anqi, et al.
Publicado: (2014)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
por: Yudushkin, Ivan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h9r5n39vcd5ddi48k0b2922mfm